THERAPEUTIC AGENT FOR PANCREATIC CANCER

摘要

The inventors have found that excellent therapeutic effects on pancreatic cancer can be achieved by administering an IL-6 inhibitor and an antimetabolite to a pancreatic cancer patient. It is also found that reduction of metastasis from human pancreatic cancer and elimination of ascites are also possible by the administration of an IL-6 inhibitor and an antimetabolite.